Language: BG BG
← Back to results
Recruiting NCT07254351

Analysis of the Biomechanical Impact of Lower Limb Length Inequality in PEDiatrics

Conditions: Lower Limb Length Discrepancy (LLD) in Children

Sponsor: Hospices Civils de Lyon

trial.available_in: БГ
Overview
Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain. The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads. This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.
Description
Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain. The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads. A temporary orthopedic compensation (shoe lift) will also be tested to assess its immediate biomechanical effect. Participants will be evaluated at baseline (two EOS acquisitions: with and without compensation) and at 2 years (without compensation). This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.
Who can participate
Inclusion Criteria: * Children aged 10-15 years * Anatomical LLD \> 5 mm, clinically measured * EOS imaging indicated by the pediatric orthopedic surgeon in routine care * Ability to stand still for 30 seconds without assistance * Covered by social security * Parental consent and non-opposition obtained Exclusion Criteria: * \- Functional or postural LLD without true anatomical discrepancy * History of major pelvic or spinal surgery * Severe neurological or orthopedic condition preventing standing (e.g. cerebral palsy, progressive myopathy) * Fixed equinus deformity preventing plantar support * Major lower limb deformity (severe genu varum/valgum) * Contraindication or inability to undergo EOS imaging
Interventions
EOS Imaging System
RADIATION
Force Platform (Bertec®, integrated into EOS cabin)
DEVICE
Locations 1
France (1)
Hospices Civils de Lyon Service d'Orthopédie et de Traumatologie
Bron
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
10 Years
Maximum age
15 Years
Healthy volunteers
No
Start date
07.04.2026
Completion date
07.06.2029
Registry ID
NCT07254351
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.